The governing board of the Cancer Prevention and Research Institute of Texas approved over $90 million in cancer research and prevention grants at its quarterly meeting on Feb. 15. The slate of forty projects from across Texas fund a wide range of research and prevention efforts at major research hubs like Dallas, San Antonio, and Houston, but also invests in rapidly developing cancer research programs in El Paso and the Rio Grande Valley.
With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere.
